|
We asked 40 pharma professionals, What is the greatest opportunity for the industry in the next 5 years?
| Personalized medicine |
53% |
| Big data |
7% |
| Emerging Markets |
20% |
| Biosimilars |
20% |
 |
|
|
|
|
|
|
|
28 January, 2014
|
|
|
Russia’s Bet on Biopharma
Can innovation trump ideology? Russia faces a stark choice in betting on the visible hand of government in promoting a "world class" biopharmaceutical sector, writes William Looney ...Read more |
Pharm Exec's Annual Industry Outlook 2014
For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. As our annual industry outlook confirms, it’s time to be decisive — muddling through is so ‘yesterday’ ... Read more
|
On-Demand Marketing Re-Invents Customer Relationships
Staying on top of the marketing information stream can be difficult for your customers, but plans for a ‘holistic’ healthcare network could make relationships easier to manage, writes Peter Houston ... Read more
|
Read the New Pharm Exec Global Digest — Regulatory Special
In this month’s Pharm Exec Global Digest — Regulating Cloud Computing; Regulators’ Three Goals for 2014; the European Regulatory Outlook; Obamacare and the US’s ‘New Medical Culture’’ and more ... Read more
|
|
| Sciformix |
 Scignal Plus: Taking the Noise Out of Signal Detection
Scignal Plus provides superior, efficient signal detection by incorporating computational algorithms for a new method and previously known methods of signal detection. It has several distinct and important advantages over other products that are available in the market.  Read more. |
|
|
|
|
|
|
|
|
